ClearBridge LLC (Maryland)’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-11,100
Closed -$74K 182
2016
Q3
$74K Sell
11,100
-7,000
-39% -$38.5K ﹤0.01% 167
2016
Q2
$88K Hold
18,100
﹤0.01% 162
2016
Q1
$88K Hold
18,100
﹤0.01% 165
2015
Q4
$157K Hold
18,100
﹤0.01% 150
2015
Q3
$264K Hold
18,100
0.01% 164
2015
Q2
$302K Buy
18,100
+700
+4% +$13.2K 0.01% 167
2015
Q1
$381K Hold
17,400
0.01% 161
2014
Q4
$377K Buy
17,400
+14,000
+412% +$212K 0.01% 161
2014
Q3
$58K Buy
+3,400
New +$54.5K ﹤0.01% 173

Other funds holding PRQR

ClearBridge LLC (Maryland)'s PRQR Position: Q4 2016 in Review

ClearBridge LLC (Maryland) sold out of ProQR Therapeutics (PRQR) in Q4 2016, closing a stake of 11,100 shares — an estimated $74K sold.

ClearBridge LLC (Maryland) first reported a position in PRQR in Q3 2014 and held it in 9 quarters. The position peaked at $381K in Q1 2015. 23 funds tracked by Wall St. Rank hold PRQR as of Q4 2016.

  • ClearBridge LLC (Maryland) reported no remaining ProQR Therapeutics position as of Q4 2016 after selling out during the quarter.
  • ClearBridge LLC (Maryland) sold 11,100 ProQR Therapeutics shares in Q4 2016, an estimated $74K.
  • ClearBridge LLC (Maryland) first reported a position in ProQR Therapeutics in Q3 2014 and held it in 9 quarters.
  • ClearBridge LLC (Maryland)'s ProQR Therapeutics position peaked at $381K in Q1 2015.
  • 23 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2016.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q4 2016, filed 14 Feb 2017.